Therefore, blockade of the GLP‐2R signal could theoretically reduce general nutrient absorption pointing towards a potential role for GLP‐2R antagonists in the treatment of obesity. This evidence concerns the gene GLP2R and obesity due to melanocortin 4 receptor deficiency.